Per Øyvind Enger

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Stephen B. Willingham, Jens-Peter Volkmer, Andrew J. Gentles et al. · Proceedings of the National Academy of Sciences · 2012 · 1.7K citations · Full text

Medicine, Immunology, Oncology +17

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

Jian Wang, Per Øystein Sakariassen, Oleg Tsinkalovsky et al. · International Journal of Cancer · 2007 · 560 citations · Full text

Medicine, Cell Biology, Oncology +17

Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level

Justyna Kmiecik, Aurélie Poli, Nicolaas H. C. Brons et al. · Journal of Neuroimmunology · 2013 · 392 citations · Full text

Life Sciences, Immunology, Oncology +17

Local endostatin treatment of gliomas administered by microencapsulated producer cells

Tracy‐Ann Read, Dag R. Sørensen, Rupavathana Mahesparan et al. · Nature Biotechnology · 2001 · 297 citations

Medicine, Oncology, Pharmacology +14

Angiogenesis-independent tumor growth mediated by stem-like cancer cells

Per Øystein Sakariassen, Lars Prestegarden, Jian Wang et al. · Proceedings of the National Academy of Sciences · 2006 · 214 citations · Full text

Medicine, Cancer Biology, Oncology +17